查詢結果分析
相關文獻
- 紅麴代謝產物(Monacolin K)對肝細胞胰島素阻抗之改善效應
- Extreme Insulin Resistance Syndrome
- The Relationship between Leptin Concentration and Insulin Resistance in Chinese Type 2 Diabetic Patients
- The Postpartum Metabolic Outcome of Women with Previous Gestational Diabetes Mellitus
- 肥胖症與胰島素抗性
- PPARγ與糖尿病
- 第2型糖尿病、游離脂肪酸、脂肪細胞激素與PPARγ促效劑
- 糖尿病夏柯氏神經骨關節病變 (Charcot’s Neuro-Osteoarthropathy) 的成因、預防及治療
- 高胰島素血症--常被忽視的代謝問題
- 糖尿病和體能活動
頁籤選單縮合
題 名 | 紅麴代謝產物(Monacolin K)對肝細胞胰島素阻抗之改善效應=Improvement Effects of Monacolin K from Monascus-Fermented Products on Insulin Resistance of Mouse Liver Cell Lines |
---|---|
作 者 | 張郁瑩; 李保宏; 黃韜; 潘子明; | 書刊名 | 臺灣農業化學與食品科學 |
卷 期 | 49:2 2011.04[民100.04] |
頁 次 | 頁82-88 |
分類號 | 369.36 |
關鍵詞 | 發炎因子; 糖尿病; 胰島素抗性; 抗氧化效應; Inflammatory factor; Diabetes; Insulin resistance; Monacolin K; Antioxidative effect; |
語 文 | 中文(Chinese) |
中文摘要 | 本研究以發炎因子tumor necrosis factor-alpha (TNF-α)處理小鼠肝臟細胞株(FL83B),使其產生胰島素抗性,並評估紅麴二次代謝物減緩胰島素抗性及改善糖尿病之能力。Monacolin K為紅麴主要活性成分,本研究探討monacolin K與TNF-α共同處理細胞24小時後,對肝細胞吞噬葡萄糖能力之影響。結果發現,monacolin K處理可提升FL83B肝細胞對螢光葡萄糖(2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose; 2-NBDG)之攝入量。本研究也發現monacolin K減緩胰島素抗性是透過增加insulin receptor substrate-2 (IRS-2)磷酸化所達成,進而增加Akt[或稱PKB/Akt,是一種serine/threonine kinase]磷酸化,使得glucose transporter 2 (GLUT 2)表現量增加,此外monacolin K也可增加胞內NADPH/NADP(上標 +)之比率,顯示monacolin K應具有抗氧化效應,而保持NADPH不被氧化。綜合試驗結果得知,紅麴之二次代謝物monacolin K除具血脂調節功能外,更可改善肝細胞之胰島素抗性,具開發成治療糖尿病藥物之潛力。 |
英文摘要 | In the present study we used tumor necrosis factor-alpha (TNF-α) to induce insulin resistance in mouse liver cell lines (FL83B). We examined the improvement effects of Monascus-fermented product, monacolin K, on insulin resistance and diabetes. Monacolin K is the main active component in Monascus-fermented products. In this study, we co-treated the mouse hepatocytes with monacolin K and TNF-α for 24 hours. First, we observed that monacolin K could increase the fluorescent glucose (2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-d-glucose; 2-NBDG) uptake in FL83B cell. We also observed that monacolin K improved insulin resistance through increasing phosphorylation of insulin receptor substrate-2 (IRS-2), which results in increasing phosphorylation of Akt. At last, it raised the expression of glucose transporter 2 (GLUT 2). In addition, monacolin K could increase the ratio of NADPH and NADP(superscript +). This indicated that monacolin K has an antioxidative effect, which could keep NADPH in a reduced form. Based on these data, we suggested that Monascus-fermented product, monacolin K, not only possesses the function of modulating blood lipids, but also improves insulin resistance in liver cells. It truly had the potential to develop into a diabetes drug. |
本系統中英文摘要資訊取自各篇刊載內容。